LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403 | -64.5% | 122 | -64.5% | 0.00% | – |
| Q2 2023 | $1,135 | -0.4% | 344 | 0.0% | 0.00% | – |
| Q1 2023 | $1,139 | -8.3% | 344 | 0.0% | 0.00% | – |
| Q4 2022 | $1,242 | -58.6% | 344 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 344 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -75.0% | 344 | -72.7% | 0.00% | – |
| Q1 2022 | $12,000 | +50.0% | 1,262 | +2.9% | 0.00% | – |
| Q4 2021 | $8,000 | -20.0% | 1,227 | +8.3% | 0.00% | – |
| Q3 2021 | $10,000 | -16.7% | 1,133 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -29.4% | 1,133 | -24.1% | 0.00% | – |
| Q1 2021 | $17,000 | -46.9% | 1,492 | +64.9% | 0.00% | – |
| Q4 2020 | $32,000 | +146.2% | 905 | -3.8% | 0.00% | – |
| Q3 2020 | $13,000 | +85.7% | 941 | +111.5% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 445 | -32.4% | 0.00% | – |
| Q1 2020 | $6,000 | – | 658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 10,175 | $70,512,000 | 0.26% |
| Minerva Advisors LLC | 34,015 | $236,000 | 0.14% |
| Investors Financial Group, LLC | 30,600 | $212,000 | 0.10% |
| Lion Point Capital, LP | 51,205 | $354,000 | 0.10% |
| NEA Management Company, LLC | 376,916 | $2,612,000 | 0.05% |
| Wealth Advisors of Iowa, LLC | 11,699 | $81,000 | 0.04% |
| Paladin Advisory Group, LLC | 4,382 | $30,000 | 0.02% |
| Marquette Asset Management, LLC | 13,315 | $92,000 | 0.02% |
| Blackstone Inc. | 468,145 | $3,244,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $331,000 | 0.01% |